Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.

Regulation of Natural Killer Cell Activity by Theophylline

Institution: University of California, Los Angeles
Investigator(s): Michael Roth, M.D.
Award Cycle: 1994 (Cycle 3) Grant #: 3RT-0146 Award: $172,231
Subject Area: Pulmonary Disease
Award Type: Research Project Awards

Inhibition of natural killer cell activity by theophylline is mediated through its affect on phosphodiesterase activity
Periodical: American Review of Respiratory Disease Index Medicus:
Authors: Coskey LA, Roth MD ABS
Yr: 1993 Vol: 147 Nbr: 4 pt 2 Abs: Pg: A314

Inhibition of natural killer cell activity by therapeutic levels of theophylline
Periodical: American Journal of Respiratory Cell and Molecular Biology Index Medicus:
Authors: Coskey LA, Bitting J, Roth MD ART
Yr: 1993 Vol: 9 Nbr: 6 Abs: Pg: 659-665

Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4
Periodical: Journal of Leukocyte Biology Index Medicus:
Authors: Kiertscher SM, Roth MD ART
Yr: 1995 Vol: Nbr: Abs: Pg: